| 000 | 01519 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516174924.0 | ||
| 264 | 0 | _c20140903 | |
| 008 | 201409s 0 0 eng d | ||
| 022 | _a1095-953X | ||
| 024 | 7 |
_a10.1016/j.nbd.2013.10.016 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBourdenx, Mathieu | |
| 245 | 0 | 0 |
_aAbnormal structure-specific peptide transmission and processing in a primate model of Parkinson's disease and l-DOPA-induced dyskinesia. _h[electronic resource] |
| 260 |
_bNeurobiology of disease _cFeb 2014 |
||
| 300 |
_a307-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xtoxicity |
| 650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xmetabolism |
| 650 | 0 | 4 |
_aEnkephalins _xanalysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlobus Pallidus _xchemistry |
| 650 | 0 | 4 |
_aLevodopa _xtoxicity |
| 650 | 0 | 4 | _aMacaca mulatta |
| 650 | 0 | 4 |
_aNeuropeptides _xanalysis |
| 650 | 0 | 4 |
_aParkinsonian Disorders _xmetabolism |
| 650 | 0 | 4 |
_aProtein Precursors _xanalysis |
| 650 | 0 | 4 |
_aPutamen _xchemistry |
| 650 | 0 | 4 |
_aTachykinins _xanalysis |
| 700 | 1 | _aNilsson, Anna | |
| 700 | 1 | _aWadensten, Henrik | |
| 700 | 1 | _aFälth, Maria | |
| 700 | 1 | _aLi, Qin | |
| 700 | 1 | _aCrossman, Alan R | |
| 700 | 1 | _aAndrén, Per E | |
| 700 | 1 | _aBezard, Erwan | |
| 773 | 0 |
_tNeurobiology of disease _gvol. 62 _gp. 307-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.nbd.2013.10.016 _zAvailable from publisher's website |
| 999 |
_c23192730 _d23192730 |
||